Colgate-Palmolive Company (CL)
CL (NYSE:Consumer Non-Durables)
$62.04

-0.34
-0.54%
Today's Range: 61.78 - 62.40 |
CL Avg Daily Volume: 3,233,900
| Last Update: 05/17/13 - 4:01 PM EDT |
| Volume: 4,149,203 |
| YTD Performance: 18.69%
|
| Open: $62.14 |
| Previous Close: $62.38 |
| 52 Week Range: $48.11 -
$62.70 |
| Oustanding Shares: 932,737,734 |
| Market Cap: 58,184,179,847 |
6-Month Chart
TheStreet Ratings Grade for CL
| Buy |
Hold
|
Sell
|
| A+ |
A |
A- |
B+ |
B |
B- |
C+ |
C |
C- |
D+ |
D |
D- |
E+ |
E |
E- |
F |
Analysts Ratings
| Historical Rec |
Current |
1 Mo. Ago |
2 Mo. Ago |
3 Mo. Ago |
| Strong Buy |
3 |
3 |
3 |
4 |
| Moderate Buy |
1 |
1 |
1 |
2 |
| Hold |
15 |
14 |
15 |
13 |
| Moderate Sell |
0 |
0 |
0 |
0 |
| Strong Sell |
1 |
2 |
2 |
2 |
| Mean Rec. |
2.75 |
2.85 |
2.86 |
2.69 |
| Latest Dividend: |
0.34 |
| Latest Dividend Yield: |
2.18% |
| Dividend Ex-Date: |
04/19/13 |
| Price Earnings Ratio: |
25.57 |
|
| Price Earnings Comparisons: |
| CL |
Sector Avg. |
S&P 500 |
| 25.57 |
25.50 |
17.70 |
| Price Performance History (%Change): |
| 3 Mo |
1 Yr |
3 Y |
|
12.78%
|
24.32%
|
48.05%
|
|
| GROWTH |
12 Mo |
3 Yr |
CAGR |
| Revenue |
2.10 |
0.11 |
0.04 |
| Net Income |
0.00 |
0.00 |
0.00 |
| EPS |
4.30 |
0.15 |
0.05 |
| Earnings for CL: |
| EBITDA |
4.40B |
| Revenue |
17.09B |
|
Average Earnings Estimates
;Qtr (09/13);FY (12/13);FY (12/14)&HEADING_LIST1=Qtr (06/12);Qtr (09/12);FY (12/12);FY (12/13)) |
|
| Average Estimate |
$0.70 |
$0.74 |
$2.86 |
$3.15 |
| Number of Analysts |
15 |
14 |
15 |
16 |
| High Estimate |
$0.72 |
$0.75 |
$2.88 |
$3.20 |
| Low Estimate |
$0.69 |
$0.73 |
$2.83 |
$3.10 |
| Prior Year |
$0.67 |
$0.69 |
$2.68 |
$2.86 |
| Growth Rate (Year over Year) |
5.46% |
7.35% |
6.55% |
10.34% |
By |
Sep 25, 2012 | 10:58 AM EDT
We see good strength across the board in defensive staples.
By |
Sep 20, 2012 | 10:02 AM EDT
A possible first-quarter 2013 approval for Eliquis could be an important catalyst for the shares.
By |
Sep 19, 2012 | 12:22 PM EDT
Every single defensive stock on my screen is in the green.
By |
Sep 18, 2012 | 2:27 PM EDT
I expect a continuation of this rotation in the weeks ahead.
By |
Sep 7, 2012 | 7:43 AM EDT
Currently, only three out of the 70 stocks I have mentioned recently are eligible to buy, down considerably from 19 out of 69 in late July.
By |
Jul 31, 2012 | 8:10 AM EDT
Let's see how the manufacturing data stack up over the next 24 hours.
By |
Jul 30, 2012 | 2:26 PM EDT
They include the strength in the U.S. bond market (lower yields), weakness in the euro and continued leadership from consumer staples.
By |
Jul 30, 2012 | 11:37 AM EDT
Jim Cramer says he is most anxiously awaiting P&G's earnings.
By |
Jul 27, 2012 | 8:24 AM EDT
Deutsche Bank downgrades Colgate-Palmolive.
Colgate-Palmolive numebrs raised at UBS
Jul 27, 2012 | 8:06 AM EDT
Shares of CL now seen reaching $104, UBS said. Estimates also increased as underlying fundamentals improve despite FX impact. Neutral rating.